• Tagrix-80mg (Osimertinib) Quick View
    • Tagrix-80mg (Osimertinib) Quick View
    • Tagrix-80mg (Osimertinib)

    • Tagrix-80mg (Osimertinib) is a life-changing medication designed to target and treat non-small cell lung cancer (NSCLC) that has specific EGFR (epidermal growth factor receptor) mutations. As an advanced third-generation EGFR inhibitor, it offers hope to patients who have developed resistance to earlier treatments. Tagrix is especially effective against tumors that harbor the T790M mutation, providing a tailored approach to Treatment…
    • Read more